Clinical Trials Browser

NIH × Neurofibromatosis 2 × Bevacizumab × Clear all

NCT01207687 2018-08-27

Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)

Phase 2 Completed

14 enrolled 28 charts

Neuroma, Acoustic, Neurofibromatosis 2